Canamex: Robert Kramer sold $10M in stock before news of J&J vaccine mishap

The CEO of the Baltimore lab that botched 15 million doses of the Johnson & Johnson vaccine last month sold more than $10 million worth of shares in his company before it disclosed the disastrous mistake. Robert Kramer, chief executive of Emergent BioSolutions, sold the massive chunk of stock in January and February - when [...]The post Robert Kramer sold $10M in stock before news of J&J vaccine mishap appeared first on News Brig.